According to Hoth Therapeutics's latest financial reports the company's current EPS (TTM) is -5,80ย โฌ. In 2022 the company made an earnings per share (EPS) of -8,96ย โฌ an increase over its 2021 EPS that were of -15,41ย โฌ.